MicroRNA-144 is regulated by activator protein-1 (AP-1) and decreases expression of alzheimer disease-related a disintegrin and metalloprotease 10 (ADAM10)

Journal of Biological Chemistry

Volumn 288, Issue 19, 2013, Pages 13748-13761

  Cheng, Cong ^a   Li, Weiguang ^a   Zhang, Zheng ^a   Yoshimura, Shohei ^b   Hao, Qinyu ^a   Zhang, Chi ^a   Wang, Zhao ^a  

^a Tsinghua University   (China)

^b OKAYAMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATOR PROTEIN-1; ALZHEIMER; ALZHEIMER DISEASE; METALLO-PROTEASE; MICRORNAS; NEGATIVE REGULATORS;

NEURODEGENERATIVE DISEASES; RNA;

PROTEINS;

ADAM10 ENDOPEPTIDASE; AMYLOID BETA PROTEIN; LUCIFERASE; MICRORNA; MICRORNA 144; REGULATOR PROTEIN; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN LEVEL; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; GENE CONTROL; GENE FUNCTION; GENE LOCUS; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MOLECULAR RECOGNITION; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PRIMATE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS INHIBITION; PROTEIN SYNTHESIS REGULATION; PROTEIN TARGETING; REGULATORY MECHANISM; RNA ANALYSIS; RNA BINDING; RNA PROCESSING; TRANSCRIPTION REGULATION; UPREGULATION;

ADAM ADAMTS; ADAM10; ALZHEIMERS DISEASE; AMYLOID; GENE REGULATION; MICRORNA; MIR-144;

3' UNTRANSLATED REGIONS; ADAM PROTEINS; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; AMYLOID PRECURSOR PROTEIN SECRETASES; BASE SEQUENCE; BINDING SITES; ENZYME REPRESSION; GENES, REPORTER; HELA CELLS; HUMANS; MEMBRANE PROTEINS; MICRORNAS; PROMOTER REGIONS, GENETIC; RESPONSE ELEMENTS; RNA INTERFERENCE; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION, GENETIC;

EID: 84877699276     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M112.381392     Document Type: Article

References (70)

1. Blennow, K., de Leon, M. J., and Zetterberg, H. (2006) Alzheimer's disease. Lancet 368, 387-403
2. Tanzi, R. E., and Bertram, L. (2005) Twenty years of the Alzheimer's disease amyloid hypothesis. A genetic perspective. Cell 120, 545-555
3. Postina, R., Schroeder, A., Dewachter, I., Bohl, J., Schmitt, U., Kojro, E., Prinzen, C., Endres, K., Hiemke, C., Blessing, M., Flamez, P., Dequenne, A., Godaux, E., van Leuven, F., and Fahrenholz, F. (2004) A disintegrinmetalloproteinase prevents amyloid plaque formation and hippocampal defects in an Alzheimer disease mouse model. J. Clin. Invest. 113, 1456-1464
4. Postina, R. (2008) A closer look at α-secretase. Curr. Alzheimer Res 5, 179-186
5. Colciaghi, F., Borroni, B., Pastorino, L., Marcello, E., Zimmermann, M., Cattabeni, F., Padovani, A., and Di Luca, M. (2002) α-Secretase ADAM10 as well as αAPPs is reduced in platelets and CSF of Alzheimer disease patients. Mol. Med. 8, 67-74
6. Bernstein, H. G., Bukowska, A., Krell, D., Bogerts, B., Ansorge, S., and Lendeckel, U. (2003) Comparative localization of ADAMs 10 and 15 in human cerebral cortex normal aging, Alzheimer disease and Down syndrome. J. Neurocytol. 32, 153-160
7. Lammich, S., Kojro, E., Postina, R., Gilbert, S., Pfeiffer, R., Jasionowski, M., Haass, C., and Fahrenholz, F. (1999) Constitutive and regulated α-secretase cleavage of Alzheimer's amyloid precursor protein by a disintegrin metalloprotease. Proc. Natl. Acad. Sci. U.S.A. 96, 3922-3927
8. Jorissen, E., Prox, J., Bernreuther, C., Weber, S., Schwanbeck, R., Serneels, L., Snellinx, A., Craessaerts, K., Thathiah, A., Tesseur, I., Bartsch, U., Weskamp, G., Blobel, C. P., Glatzel, M., De Strooper, B., and Saftig, P. (2010) The disintegrin/metalloproteinase ADAM10 is essential for the establishment of the brain cortex. J. Neurosci. 30, 4833-4844
9. Kuhn, P. H., Wang, H., Dislich, B., Colombo, A., Zeitschel, U., Ellwart, J. W., Kremmer, E., Rossner, S., and Lichtenthaler, S. F. (2010) ADAM10 is the physiologically relevant, constitutive α-secretase of the amyloid precursor protein in primary neurons. EMBO J. 29, 3020-3032
10. Sennvik, K., Fastbom, J., Blomberg, M., Wahlund, L. O., Winblad, B., and Benedikz, E. (2000) Levels of α-and β-secretase cleaved amyloid precursor protein in the cerebrospinal fluid of Alzheimer's disease patients. Neurosci. Lett. 278, 169-172
11. Fellgiebel, A., Kojro, E., Müller, M. J., Scheurich, A., Schmidt, L. G., and Fahrenholz, F. (2009) CSF APPsα and phosphorylated tau protein levels in mild cognitive impairment and dementia of Alzheimer's type. J. Geriatr. Psychiatry Neurol. 22, 3-9
12. Bartel, D. P. (2004) MicroRNAs. Genomics, biogenesis, mechanism, and function. Cell 116, 281-297
13. Nilsen, T. W. (2007) Mechanisms of microRNA-mediated gene regulation in animal cells. Trends Genet. 23, 243-249
14. Mehler, M. F., and Mattick, J. S. (2006) Non-coding RNAs in the nervous system. J. Physiol. 575, 333-341
15. Vo, N., Klein, M. E., Varlamova, O., Keller, D. M., Yamamoto, T., Goodman, R. H., and Impey, S. (2005) A cAMP-response element binding protein-induced microRNA regulates neuronal morphogenesis. Proc. Natl. Acad. Sci. U.S.A. 102, 16426-16431
16. Yu, J. Y., Chung, K. H., Deo, M., Thompson, R. C., and Turner, D. L. (2008) MicroRNA miR-124 regulates neurite outgrowth during neuronal differentiation. Exp. Cell Res. 314, 2618-2633
17. Schratt, G. M., Tuebing, F., Nigh, E. A., Kane, C. G., Sabatini, M. E., Kiebler, M., and Greenberg, M. E. (2006) A brain-specific microRNA regulates dendritic spine development. Nature 439, 283-289
18. Leucht, C., Stigloher, C., Wizenmann, A., Klafke, R., Folchert, A., and Bally-Cuif, L. (2008) MicroRNA-9 directs late organizer activity of the midbrain-hindbrain boundary. Nat. Neurosci. 11, 641-648
19. Laneve, P., Gioia, U., Andriotto, A., Moretti, F., Bozzoni, I., and Caffarelli, E. (2010) A minicircuitry involving REST and CREB controls miR-9-2 expression during human neuronal differentiation. Nucleic Acids Res. 38, 6895-6905
20. Conaco, C., Otto, S., Han, J. J., and Mandel, G. (2006) Reciprocal actions of REST and a microRNA promote neuronal identity. Proc. Natl. Acad. Sci. U.S.A. 103, 2422-2427
21. Hébert, S. S., and De Strooper, B. (2009) Alterations of the microRNA network cause neurodegenerative disease. Trends Neurosci. 32, 199-206
22. Johnson, R., Zuccato, C., Belyaev, N. D., Guest, D. J., Cattaneo, E., and Buckley, N. J. (2008) A microRNA-based gene dysregulation pathway in Huntington's disease. Neurobiol. Dis. 29, 438-445
23. Hébert, S. S., Horré, K., Nicolaï, L., Bergmans, B., Papadopoulou, A. S., Delacourte, A., and De Strooper, B. (2009) MicroRNA regulation of Alzheimer's amyloid precursor protein expression. Neurobiol. Dis. 33, 422-428
24. Patel, N., Hoang, D., Miller, N., Ansaloni, S., Huang, Q., Rogers, J. T., Lee, J. C., and Saunders, A. J. (2008) MicroRNAs can regulate human APP levels. Mol. Neurodegeneration 3, 10-15
25. Vilardo, E., Barbato, C., Ciotti, M., Cogoni, C., and Ruberti, F. (2010) MicroRNA-101 regulates amyloid precursor protein expression in hippocampal neurons. J. Biol. Chem. 285, 18344-18351
26. Long, J. M., and Lahiri, D. K. (2011) MicroRNA-101 downregulates Alzheimer's amyloid-β precursor protein levels in human cell cultures and is differentially expressed. Biochem. Biophys. Res. Commun. 404, 889-895
27. Liu, W., Liu, C., Zhu, J., Shu, P., Yin, B., Gong, Y., Qiang, B., Yuan, J., and Peng, X. (2012) MicroRNA-16 targets amyloid precursor protein to potentially modulate Alzheimer's-associated pathogenesis in SAMP8 mice. Neurobiol. Aging 33, 522-534
28. Wang, W. X., Rajeev, B. W., Stromberg, A. J., Ren, N., Tang, G., Huang, Q., Rigoutsos, I., and Nelson, P. T. (2008) The expression of microRNA miR-107 decreases early in Alzheimer's disease and may accelerate disease progression through regulation of β-site amyloid precursor protein-cleaving enzyme 1. J. Neurosci. 28, 1213-1223
29. Hébert, S. S., Horré, K., Nicolaï, L., Papadopoulou, A. S., Mandemakers, W., Silahtaroglu, A. N., Kauppinen, S., Delacourte, A., and De Strooper, B. (2008) Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer's disease correlates with increased BACE1/β-secretase expression. Proc. Natl. Acad. Sci. U.S.A. 105, 6415-6420
30. Boissonneault, V., Plante, I., Rivest, S., and Provost, P. (2009) MicroRNA-298 and microRNA-328 regulate expression of mouse β-amyloid precursor protein-converting enzyme 1. J. Biol. Chem. 284, 1971-1981
31. Hansson, M. D., Rzeznicka, K., Rosenbäck, M., Hansson, M., and Sirijovski, N. (2008) PCR-mediated deletion of plasmid DNA. Anal. Biochem. 375, 373-375
32. Persengiev, S., Kondova, I., Otting, N., Koeppen, A. H., and Bontrop, R. E. (2011) Genome-wide analysis of miRNA expression reveals a potential role for miR-144 in brain aging and spinocerebellar ataxia pathogenesis. Neurobiol. Aging 32, 2316.e2317-2316.e2327
33. Augustin, R., Endres, K., Reinhardt, S., Kuhn, P. H., Lichtenthaler, S. F., Hansen, J., Wurst, W., and Trümbach, D. (2012) Computational identification and experimental validation of microRNAs binding to the Alzheimer-related gene ADAM10. BMC Med. Genet. 13, 35
34. Bai, S., Nasser, M. W., Wang, B., Hsu, S. H., Datta, J., Kutay, H., Yadav, A., Nuovo, G., Kumar, P., and Ghoshal, K. (2009) MicroRNA-122 inhibits tumorigenic properties of hepatocellular carcinoma cells and sensitizes these cells to sorafenib. J. Biol. Chem. 284, 32015-32027
35. Lewis, B. P., Shih, I. H., Jones-Rhoades, M. W., Bartel, D. P., and Burge, C. B. (2003) Prediction of mammalian microRNA targets. Cell 115, 787-798
36. Chien, C. H., Sun, Y. M., Chang, W. C., Chiang-Hsieh, P. Y., Lee, T. Y., Tsai, W. C., Horng, J. T., Tsou, A. P., and Huang, H. D. (2011) Identifying transcriptional start sites of human microRNAs based on high-throughput sequencing data. Nucleic Acids Res. 39, 9345-9356
37. Kawaji, H., Severin, J., Lizio, M., Waterhouse, A., Katayama, S., Irvine, K. M., Hume, D. A., Forrest, A. R., Suzuki, H., Carninci, P., Hayashizaki, Y., and Daub, C. O. (2009) The FANTOM web resource. From mammalian transcriptional landscape to its dynamic regulation. Genome Biol. 10, R40
38. Kawaji, H., Severin, J., Lizio, M., Forrest, A. R., van Nimwegen, E., Rehli, M., Schroder, K., Irvine, K., Suzuki, H., Carninci, P., Hayashizaki, Y., and Daub, C. O. (2011) Update of the FANTOM web resource. From mammalian transcriptional landscape to its dynamic regulation. Nucleic Acids Res. 39, D856-860
39. Halazonetis, T. D., Georgopoulos, K., Greenberg, M. E., and Leder, P. (1988) c-Jun dimerizes with itself and with c-Fos, forming complexes of different DNA binding affinities. Cell 55, 917-924
40. Rauscher, F. J., 3rd, Voulalas, P. J., Franza, B. R., Jr., and Curran, T. (1988) Fos and Jun bind cooperatively to the AP-1 site. Reconstitution in vitro. Genes Dev. 2, 1687-1699
41. Chiu, R., Boyle, W. J., Meek, J., Smeal, T., Hunter, T., and Karin, M. (1988) The c-Fos protein interacts with c-Jun/AP-1 to stimulate transcription of AP-1 responsive genes. Cell 54, 541-552
42. Angel, P., Imagawa, M., Chiu, R., Stein, B., Imbra, R. J., Rahmsdorf, H. J., Jonat, C., Herrlich, P., and Karin, M. (1987) Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated transacting factor. Cell 49, 729-739
43. Lee, W., Mitchell, P., and Tjian, R. (1987) Purified transcription factor AP-1 interacts with TPA-inducible enhancer elements. Cell 49, 741-752
44. Anderson, A. J., Pike, C. J., and Cotman, C. W. (1995) Differential induction of immediate early gene proteins in cultured neurons by β-amyloid (Aβ). Association of c-Jun with A β-induced apoptosis. J. Neurochem. 65, 1487-1498
45. Marcus, D. L., Strafaci, J. A., Miller, D. C., Masia, S., Thomas, C. G., Rosman, J., Hussain, S., and Freedman, M. L. (1998) Quantitative neuronal c-fos and c-jun expression in Alzheimer's disease. Neurobiol. Aging 19, 393-400
46. Thakur, A., Wang, X., Siedlak, S. L., Perry, G., Smith, M. A., and Zhu, X. (2007) c-Jun phosphorylation in Alzheimer disease. J. Neurosci. Res. 85, 1668-1673
47. Vukic, V., Callaghan, D., Walker, D., Lue, L. F., Liu, Q. Y., Couraud, P. O., Romero, I. A., Weksler, B., Stanimirovic, D. B., and Zhang, W. (2009) Expression of inflammatory genes induced by β-amyloid peptides in human brain endothelial cells and in Alzheimer's brain is mediated by the JNK-AP1 signaling pathway. Neurobiol. Dis. 34, 95-106
48. Xu, J., Chen, S., Ahmed, S. H., Chen, H., Ku, G., Goldberg, M. P., and Hsu, C. Y. (2001) Amyloid-β peptides are cytotoxic to oligodendrocytes. J. Neurosci. 21, RC118
49. Yin, K. J., Lee, J. M., Chen, S. D., Xu, J., and Hsu, C. Y. (2002) Amyloid-β induces Smac release via AP-1/Bim activation in cerebral endothelial cells. J. Neurosci. 22, 9764-9770
50. Roher, A. E., Lowenson, J. D., Clarke, S., Woods, A. S., Cotter, R. J., Gowing, E., and Ball, M. J. (1993) β-Amyloid-(1-42) is a major component of cerebrovascular amyloid deposits. Implications for the pathology of Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A. 90, 10836-10840
51. Selkoe, D. J. (2001) Alzheimer's disease. Genes, proteins, and therapy. Physiol. Rev. 81, 741-766
52. Dore, L. C., Amigo, J. D., Dos Santos, C. O., Zhang, Z., Gai, X., Tobias, J. W., Yu, D., Klein, A. M., Dorman, C., Wu, W., Hardison, R. C., Paw, B. H., and Weiss, M. J. (2008) A GATA-1-regulated microRNA locus essential for erythropoiesis. Proc. Natl. Acad. Sci. U.S.A. 105, 3333-3338
53. Zhang, X., Wang, X., Zhu, H., Zhu, C., Wang, Y., Pu, W. T., Jegga, A. G., and Fan, G. C. (2010) Synergistic effects of the GATA-4-mediated miR-144/451 cluster in protection against simulated ischemia/reperfusion-induced cardiomyocyte death. J. Mol. Cell. Cardiol. 49, 841-850
54. Yankner, B. A. (2000) A century of cognitive decline. Nature 404, 125
55. de la Monte, S. M. (2012) Brain insulin resistance and deficiency as therapeutic targets in Alzheimer's disease. Curr. Alzheimer Res. 9, 35-66
56. Karolina, D. S., Armugam, A., Tavintharan, S., Wong, M. T., Lim, S. C., Sum, C. F., and Jeyaseelan, K. (2011) MicroRNA 144 impairs insulin signaling by inhibiting the expression of insulin receptor substrate 1 in type 2 diabetes mellitus. PLoS One 6, e22839
57. Prinzen, C., Müller, U., Endres, K., Fahrenholz, F., and Postina, R. (2005) Genomic structure and functional characterization of the human ADAM10 promoter. FASEB J. 19, 1522-1524
58. Donmez, G., Wang, D., Cohen, D. E., and Guarente, L. (2010) SIRT1 suppresses β-amyloid production by activating the α-secretase gene ADAM10. Cell 142, 320-332
59. Doberstein, K., Pfeilschifter, J., and Gutwein, P. (2011) The transcription factor PAX2 regulates ADAM10 expression in renal cell carcinoma. Carcinogenesis 32, 1713-1723
60. Lee, S. B., Doberstein, K., Baumgarten, P., Wieland, A., Ungerer, C., Bürger, C., Hardt, K., Boehncke, W. H., Pfeilschifter, J., Mihic-Probst, D., Mittelbronn, M., and Gutwein, P. (2011) PAX2 regulates ADAM10 expression and mediates anchorage-independent cell growth of melanoma cells. PLoS One 6, e22312
61. Lammich, S., Buell, D., Zilow, S., Ludwig, A. K., Nuscher, B., Lichtenthaler, S. F., Prinzen, C., Fahrenholz, F., and Haass, C. (2010) Expression of the anti-amyloidogenic secretase ADAM10 is suppressed by its 5′-untranslated region. J. Biol. Chem. 285, 15753-15760
62. Moss, M. L., Bomar, M., Liu, Q., Sage, H., Dempsey, P., Lenhart, P. M., Gillispie, P. A., Stoeck, A., Wildeboer, D., Bartsch, J. W., Palmisano, R., and Zhou, P. (2007) The ADAM10 prodomain is a specific inhibitor of ADAM10 proteolytic activity and inhibits cellular shedding events. J. Biol. Chem. 282, 35712-35721
63. Gatta, L. B., Albertini, A., Ravid, R., and Finazzi, D. (2002) Levels of β-secretase BACE and α-secretase ADAM10 mRNAs in Alzheimer hippocampus. Neuroreport 13, 2031-2033
64. Misawa, A., Katayama, R., Koike, S., Tomida, A., Watanabe, T., and Fujita, N. (2010) AP-1-dependent miR-21 expression contributes to chemoresistance in cancer stem cell-like SP cells. Oncol. Res. 19, 23-33
65. Zhu, Q., Wang, Z., Hu, Y., Li, J., Li, X., Zhou, L., and Huang, Y. (2012) miR-21 promotes migration and invasion by the miR-21-PDCD4-AP-1 feedback loop in human hepatocellular carcinoma. Oncol. Rep. 27, 1660-1668
66. Galardi, S., Mercatelli, N., Farace, M. G., and Ciafrè, S. A. (2011) NF-κB and c-Jun induce the expression of the oncogenic miR-221 and miR-222 in prostate carcinoma and glioblastoma cells. Nucleic Acids Res. 39, 3892-3902
67. Zhu, X., Raina, A. K., Rottkamp, C. A., Aliev, G., Perry, G., Boux, H., and Smith, M. A. (2001) Activation and redistribution of c-jun N-terminal kinase/stress activated protein kinase in degenerating neurons in Alzheimer's disease. J. Neurochem. 76, 435-441
68. Estus, S., Zaks, W. J., Freeman, R. S., Gruda, M., Bravo, R., and Johnson, E. M., Jr. (1994) Altered gene expression in neurons during programmed cell death. Identification of c-jun as necessary for neuronal apoptosis. J. Cell Biol. 127, 1717-1727
69. Ham, J., Babij, C., Whitfield, J., Pfarr, C. M., Lallemand, D., Yaniv, M., and Rubin, L. L. (1995) A c-Jun dominant negative mutant protects sympathetic neurons against programmed cell death. Neuron 14, 927-939
70. Bozyczko-Coyne, D., Saporito, M. S., and Hudkins, R. L. (2002) Targeting the JNK pathway for therapeutic benefit in CNS disease. Curr. Drug Targets CNS Neurol. Disord. 1, 31-49